|
YEATS4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.458900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.804900E-04 |
| Normal-vs-Stage2 |
1.485830E-02 |
| Normal-vs-Stage3 |
2.669000E-01 |
| Normal-vs-Stage4 |
9.301800E-01 |
| Stage1-vs-Stage2 |
8.571200E-01 |
| Stage1-vs-Stage3 |
1.768760E-01 |
| Stage1-vs-Stage4 |
7.992400E-02 |
| Stage2-vs-Stage3 |
3.670000E-01 |
| Stage2-vs-Stage4 |
1.270620E-01 |
| Stage3-vs-Stage4 |
4.536600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.571100E-04 |
| Normal-vs-AfricanAmerican |
3.020200E-01 |
| Normal-vs-Asian |
1.672440E-01 |
| Caucasian-vs-AfricanAmerican |
7.361700E-02 |
| Caucasian-vs-Asian |
8.882000E-01 |
| AfricanAmerican-vs-Asian |
5.851000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.217860E-03 |
| Normal-vs-Female |
1.000160E-01 |
| Male-vs-Female |
1.200620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.486100E-02 |
| Normal-vs-Extreme_Weight |
7.53360000000924E-05 |
| Normal-vs-Obese |
2.772200E-02 |
| Normal-vs-Extreme_Obese |
1.045240E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.363800E-01 |
| Normal_Weight-vs-Obese |
7.529800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.307400E-01 |
| Extreme_Weight-vs-Obese |
8.522200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.917400E-01 |
| Obese-vs-Extreme_Obese |
3.007400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.423600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.929670E-02 |
| Normal-vs-Age(61-80Yrs) |
1.475680E-03 |
| Normal-vs-Age(81-100Yrs) |
2.203100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.123900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.202500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.230300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.715980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.775240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.916600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.044400E-04 |
| Normal-VS-Type2 PRCC |
2.644100E-03 |
| Normal-VS-KIRP CIMP |
9.338200E-01 |
| Normal-VS-Unclassified PRCC |
1.292240E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.844400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.234400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.920600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.150590E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.969600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.628400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.553200E-04 |
| Normal-vs-N1 |
5.183400E-01 |
| Normal-vs-N2 |
9.772200E-02 |
| N0-vs-N1 |
2.256600E-03 |
| N0-vs-N2 |
8.896400E-01 |
| N1-vs-N2 |
2.462600E-01 |
|
|
